Uveal melanoma
RecruitingStudy on Melatonin for Patients with Uveal Melanoma to Prevent Metastasis
- Disease:Uveal melanoma
- Substances:Melatonin
Sweden- Participants:18–64 years · 65+ years
- Substances:Melatonin
- Sponsor:St Erik Eye Hospital
Rare diseases
Investigational molecules
Locations
Polhemsgatan 50, Vastermalm, 112 30 Stockholm, Sweden
St Erik Eye Hospital in Stockholm, Sweden specialises in clinical trials of conditions such as Uveal melanoma, and other specialisations. This site conducts important research.
The medical center is at the forefront of ophthalmic oncology, focusing on innovative treatments for eye-related cancers. The ongoing research in this field is dedicated to improving outcomes for patients with rare ocular malignancies.
Through pioneering studies, the center is exploring the potential of adjuvant therapies to reduce metastasis and improve survival rates in patients with uveal melanoma.
Clinical trials currently enrolling participants at this site.
SwedenGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.